Alvarez E - Search Results

1

Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: a multivariate analysis of a large naturalistic study in the hospital setting.

Cañas F, Ciudad A, Gutiérrez M, Gibert J, Gascón J, Carrasco JL, Bobes J, Gómez JC, Alvarez E. Cañas F, et al. Among authors: alvarez e. Med Clin (Barc). 2005 Apr 9;124(13):481-6. doi: 10.1157/13073560. Med Clin (Barc). 2005. PMID: 15847764

2

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.

Alvarez E, Bobes J, Gómez JC, Sacristán JA, Cañas F, Carrasco JL, Gascón J, Gibert J, Gutiérrez M; EUROPA Study Group. Alvarez E, et al. Eur Neuropsychopharmacol. 2003 Jan;13(1):39-48. doi: 10.1016/s0924-977x(02)00079-2. Eur Neuropsychopharmacol. 2003. PMID: 12480121 Clinical Trial.

3

Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients.

Bobes J, Gibert J, Ciudad A, Alvarez E, Cañas F, Carrasco JL, Gascón J, Gómez JC, Gutiérrez M. Bobes J, et al. Among authors: alvarez e. Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):473-81. doi: 10.1016/S0278-5846(03)00035-6. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12691783 Clinical Trial.

4

Safety and effectiveness of olanzapine in monotherapy: a multivariate analysis of a naturalistic study.

Ciudad A, Gutiérrez M, Cañas F, Gibert J, Gascón J, Carrasco JL, Bobes J, Gómez JC, Alvarez E. Ciudad A, et al. Among authors: alvarez e. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):944-51. doi: 10.1016/j.pnpbp.2005.04.037. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15950351 Clinical Trial.

5

A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia.

Alvarez E, Ciudad A, Olivares JM, Bousoño M, Gómez JC. Alvarez E, et al. J Clin Psychopharmacol. 2006 Jun;26(3):238-49. doi: 10.1097/01.jcp.0000222513.63767.de. J Clin Psychopharmacol. 2006. PMID: 16702888 Clinical Trial.

6

Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.

Ciudad A, Olivares JM, Bousoño M, Gómez JC, Alvarez E. Ciudad A, et al. Among authors: alvarez e. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1515-22. doi: 10.1016/j.pnpbp.2006.05.010. Epub 2006 Jul 3. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16820255 Clinical Trial.

7

Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms.

Gurpegui M, Alvarez E, Bousoño M, Ciudad A, Carlos Gómez J, Olivares JM. Gurpegui M, et al. Among authors: alvarez e. Eur Neuropsychopharmacol. 2007 Nov;17(11):725-34. doi: 10.1016/j.euroneuro.2007.04.003. Epub 2007 May 31. Eur Neuropsychopharmacol. 2007. PMID: 17543505 Clinical Trial.

8

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.

San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I. San L, et al. Among authors: alvarez e. Eur Psychiatry. 2007 Nov;22(8):490-8. doi: 10.1016/j.eurpsy.2007.06.005. Epub 2007 Sep 27. Eur Psychiatry. 2007. PMID: 17904337

9

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms.

Olivares JM, Álvarez E, Carrasco JL, Pérez Páramo M, López-Gómez V. Olivares JM, et al. Among authors: alvarez e. Int Clin Psychopharmacol. 2015 Sep;30(5):265-71. doi: 10.1097/YIC.0000000000000087. Int Clin Psychopharmacol. 2015. PMID: 26111356

10

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.

De Salas-Cansado M, Olivares JM, Alvarez E, Carrasco JL, Barrueta A, Rejas J. De Salas-Cansado M, et al. Among authors: alvarez e. Clinicoecon Outcomes Res. 2012;4:157-68. doi: 10.2147/CEOR.S31102. Epub 2012 Jun 13. Clinicoecon Outcomes Res. 2012. PMID: 22745564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,630 results

Search Page

Filters